Alaunos Therapeutics, Inc.

TCRT · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $0.0B · 1 employees
426
SEC Filings
$1.95
Close 2026-10-30
1
Employees

Business Summary

Alaunos Therapeutics, Inc. is a preclinical-stage biopharmaceutical company developing novel, orally administered small-molecule therapeutics for obesity and related metabolic disorders, including MASLD (fatty liver disease). Its lead candidate, ALN1003, uses a non-hormonal, non-incretin mechanism of action. The company previously developed adoptive TCR-T cell therapies for oncology. It has not generated product revenue and reported a net loss of $4.2 million for the year ended December 31, 2025, with an accumulated deficit of $924.6 million.

Latest Stock Quote

TCRT 2026-10-30 $1.95 O:$1.84 H:$2.04 L:$1.675 Vol:0.8M VWAP:$1.8296
origin leaf: null

Next Earnings

expected 2026-12-17

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-312025-12-310001193125-26-134720EDGAR47K words
2025-03-312024-12-310000950170-25-047758EDGAR66K words
2024-04-012023-12-310000950170-24-038868EDGAR79K words
2023-03-072022-12-310000950170-23-006377EDGAR78K words
2022-03-302021-12-310000950170-22-004972EDGAR96K words
2021-03-012020-12-310001193125-21-063387EDGAR91K words
2020-03-022019-12-310001193125-20-058863EDGAR89K words
2019-03-052018-12-310001193125-19-063978EDGAR82K words
2018-03-012017-12-310001193125-18-067077EDGAR85K words
2017-02-162016-12-310001193125-17-046668EDGAR83K words

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-08-142026-06-300001193125-26-352421EDGAR16K words
2025-11-142025-09-300001193125-25-282988EDGAR18K words
2025-08-142025-06-300000950170-25-108887EDGAR18K words
2025-05-152025-03-310000950170-25-072709EDGAR14K words
2024-11-142024-09-300000950170-24-126793EDGAR41K words
2024-08-142024-06-300000950170-24-097142EDGAR41K words
2024-05-152024-03-310000950170-24-060075EDGAR43K words
2023-11-142023-09-300000950170-23-063354EDGAR48K words
2023-08-142023-06-300000950170-23-042486EDGAR46K words
2023-05-102023-03-310000950170-23-020088EDGAR45K words
2022-11-142022-09-300000950170-22-024695EDGAR48K words
2022-08-152022-06-300000950170-22-017225EDGAR47K words

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-10-230001193125-26-430507EDGAR1K words
2026-10-210001193125-26-427890EDGAR2K words
2026-10-130001193125-26-419829EDGAR3K words
2026-10-090001193125-26-419154EDGAR1K words
2026-09-220001193125-26-397996EDGAR1K words
2026-09-170001193125-26-393462EDGAR10K words
2026-03-020001193125-26-084084EDGAR1K words
2026-01-080001193125-26-007054EDGAR10K words
2025-12-230001193125-25-331147EDGAR1K words
2025-08-200000950170-25-110484EDGAR1K words

426 total filings indexed. 394 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACIU — AC Immune SA ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA

Tags

obesity-therapeutics metabolic-disorders fatty-liver-disease-(masld) oncology-cell-therapy-(legacy)

Company Identity

CIK0001107421
TickerTCRT
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE
Websitehttps://www.alaunos.com
Listed2005-08-24

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: 9086a21ae5d009beeb6c305a7e918da012ae5d8d912df358ff4d69cd797c6fcb
parent: f46c3995f82f30f26f47b190918cfe9fe1e2e678c3e2c49b1260cd0b43e6b808
content hash: edb6a880e8b7071727bb15f82db06a71fe7da02437b22c0322090c38256c46a7
signed: 2026-11-16T19:05:04.780Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up TCRT using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on TCRT, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/TCRT (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.